Nuveen Asset Management, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 123 filers reported holding TG THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,194,439
-66.5%
382,110
-0.5%
0.00%
-66.7%
Q2 2023$9,542,037
+121130.3%
384,140
-26.6%
0.00%0.0%
Q1 2023$7,871
+9.9%
523,337
-13.5%
0.00%0.0%
Q4 2022$7,159
-99.8%
605,147
+15.9%
0.00%
+200.0%
Q3 2022$3,090,000
+92.3%
522,029
+38.1%
0.00%0.0%
Q2 2022$1,607,000
-58.3%
378,007
-4.9%
0.00%0.0%
Q1 2022$3,856,000
-46.6%
397,559
-14.0%
0.00%
-50.0%
Q4 2021$7,222,000
-67.0%
462,058
-33.9%
0.00%
-71.4%
Q3 2021$21,869,000
-14.4%
699,119
+6.2%
0.01%
-12.5%
Q2 2021$25,545,000
-21.7%
658,532
-2.7%
0.01%
-20.0%
Q1 2021$32,613,000
-16.3%
676,609
-9.6%
0.01%
-23.1%
Q4 2020$38,942,000
+95.9%
748,604
+0.8%
0.01%
+62.5%
Q3 2020$19,879,000
+137.8%
742,884
+73.1%
0.01%
+166.7%
Q2 2020$8,361,000
+34.3%
429,214
-32.2%
0.00%0.0%
Q1 2020$6,226,000
+79.0%
632,713
+101.8%
0.00%
+200.0%
Q4 2019$3,479,000
+107.8%
313,458
+5.2%
0.00%0.0%
Q3 2019$1,674,000
-34.7%
298,008
+0.6%
0.00%0.0%
Q2 2019$2,562,000296,1860.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders